\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ physical\\ exam\\ and\\ laboratory\\ evaluation\\.\ \(0\)\
\-\ positive\\ eeg\\ with\\ right\\ temporal\\ lobe\\ eliptogenic\\ focus\\.\ \(0\)\
\-\ surgery\ \(977\)\
\-\ \\â\\€\\¢\\ ct\\ scan\\-\\-\\ low\\ density\\ mass\\ right\\ temporal\\ lobe\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\-\\-sharply\\ circumscribed\\ mass\\ right\\ temporal\\ lobe\ \(0\)\
\-\ \\ \\ \\ \\ \\ low\\ signal\\ intensity\\ on\\ t1\\ weighted\\ scans\ \(0\)\
\-\ \\ \\ \\ \\ \\ high\\ signal\\ intensity\\ of\\ t2\\ weighted\\ scans\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ homogeneous\\ enhancement\ \(0\)\
\-\ papillary\\ glioneuronal\\ tumor\\,\\ infiltrating\ \(0\)\
\-\ \\â\\€\\¢\\ dnet\ \(0\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ oligodendroglioma\ \(1\)\
\-\ \\â\\€\\¢\\ ganglioglioma\ \(1\)\
\-\ 4\\ y\\.o\\.\\ \\ boy\\ had\\ with\\ a\\ new\\ onset\\ seizure\\ disorder\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ temporal\\:\\ 0\\.3501396057289652\ \(0\)\
\-\ scans\\:\\ 0\\.26441314976176034\ \(0\)\
\-\ lobe\\:\\ 0\\.2634086228859428\ \(0\)\
\-\ eliptogenic\\:\\ 0\\.24297852222653707\ \(0\)\
\-\ weighted\\:\\ 0\\.22666325857753286\ \(0\)\
\-\ intensity\\:\\ 0\\.21576902953360486\ \(0\)\
\-\ glioneuronal\\:\\ 0\\.20605453977798477\ \(0\)\
\-\ eeg\\:\\ 0\\.1816491148910502\ \(0\)\
\-\ low\\:\\ 0\\.17436324220148822\ \(0\)\
\-\ signal\\:\\ 0\\.17225624255484737\ \(0\)\
\-\ sharply\\:\\ 0\\.17175251095106767\ \(0\)\
\-\ dnet\\:\\ 0\\.16831095348742722\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.15946456109134305\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.15946456109134305\ \(0\)\
\-\ right\\:\\ 0\\.1511190756440273\ \(0\)\
\-\ infiltrating\\:\\ 0\\.1490538278975423\ \(0\)\
\-\ papillary\\:\\ 0\\.1415879785570848\ \(0\)\
\-\ homogeneous\\:\\ 0\\.13414844841163864\ \(0\)\
\-\ focus\\:\\ 0\\.12870203554068516\ \(0\)\
\-\ disorder\\:\\ 0\\.12852022580278055\ \(0\)\
\-\ seizure\\:\\ 0\\.12643013250619478\ \(0\)\
\-\ circumscribed\\:\\ 0\\.11766032474381082\ \(0\)\
\-\ mass\\:\\ 0\\.11607088776821459\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.11469782737397276\ \(0\)\
\-\ laboratory\\:\\ 0\\.11033141669824621\ \(0\)\
\-\ new\\:\\ 0\\.10511165409454887\ \(0\)\
\-\ boy\\:\\ 0\\.1039342237958088\ \(0\)\
\-\ density\\:\\ 0\\.10074912206093199\ \(0\)\
\-\ positive\\:\\ 0\\.10011793083678434\ \(0\)\
\-\ onset\\:\\ 0\\.09756233548119164\ \(0\)\
\-\ t1\\:\\ 0\\.09466553727125447\ \(0\)\
\-\ evaluation\\:\\ 0\\.09265901318750044\ \(0\)\
\-\ scan\\:\\ 0\\.09014186097825685\ \(0\)\
\-\ enhancement\\:\\ 0\\.08745163813053429\ \(0\)\
\-\ t2\\:\\ 0\\.08741289627179948\ \(0\)\
\-\ high\\:\\ 0\\.08635038979830878\ \(0\)\
\-\ physical\\:\\ 0\\.08238311300605294\ \(0\)\
\-\ surgery\\:\\ 0\\.08168714643878956\ \(0\)\
\-\ tumor\\:\\ 0\\.07947127183859723\ \(0\)\
\-\ mri\\:\\ 0\\.07799039102213827\ \(0\)\
\-\ exam\\:\\ 0\\.07648458966652166\ \(0\)\
\-\ had\\:\\ 0\\.0757000334498868\ \(0\)\
\-\ normal\\:\\ 0\\.062034394284199365\ \(0\)\
\-\ with\\:\\ 0\\.05950188309404443\ \(0\)\
\-\ ct\\:\\ 0\\.057843409719997636\ \(0\)\
\-\ on\\:\\ 0\\.04588723870606153\ \(0\)\
\-\ and\\:\\ 0\\.03139568604266465\ \(0\)\
\-\ of\\:\\ 0\\.029733175981458318\ \(0\)\
